Patient-Reported and Clinical Outcomes Among Patients With Calciphylaxis.
Wen Wen, Scott Krinsky, Daniela Kroshinsky...
https://pubmed.ncbi.nlm.nih.gov/36712824/Actively Recruiting
Led by Massachusetts General Hospital · Updated on 2026-09-14
300
Participants Needed
1
Research Sites
N/A
Total Duration
Calciphylaxis is a rare and serious vascular calcification disorder that affects the small blood vessels in the skin. The condition is not well understood, with significant gaps in knowledge about its causes and risk factors. Currently, there is no effective treatment for calciphylaxis, and challenges such as its rare occurrence and limited collaborative research have hindered progress in care. This research project, known as the Partners Calciphylaxis Biorepository PCB, aims to improve understanding of calciphylaxis by collecting and storing patient samples through an organized repository. The study collaborates with the Partners Biobank, which manages the storage and distribution of these samples following their procedures. There is no intervention or treatment administered in this study. Participants will provide consent and contribute samples for research purposes. The study will track outcomes including changes in skin lesions over 6 months, pain improvements within 4 weeks, and survival up to 5 years. The study is observational and involves monitoring patients over time without active treatment. Participation may last several years as researchers collect data and samples to better understand calciphylaxis.
CONDITIONS
Partners Calciphylaxis Biobank
S
Sagar U Nigwekar, MD, MMSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Massachusetts General Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants provide consent and contribute samples for research. They are monitored over time for changes in skin lesions, pain levels, and survival without receiving any treatment.
Regular visits as scheduled by the study
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Wen Wen, Scott Krinsky, Daniela Kroshinsky...
https://pubmed.ncbi.nlm.nih.gov/36712824/Sagar U Nigwekar, Daniela Kroshinsky, Rosalynn M Nazarian...
https://pubmed.ncbi.nlm.nih.gov/25960299/Sagar U Nigwekar, Donald B Bloch, Rosalynn M Nazarian...
https://pubmed.ncbi.nlm.nih.gov/28049648/Sagar U Nigwekar, Sophia Zhao, Julia Wenger...
https://pubmed.ncbi.nlm.nih.gov/27080977/Massachusetts General Hospital
Lead Sponsor